News in the Life Sciences Industry

LONDON, April 3, 2019 /PRNewswire/ -- ECH, the group of companies behind the launch of the UK's first medical cannabis clinic, has today reinforced its ambition to expand patient access by appointing Hannah Deacon as its Patient Advocacy Specialist.

OSLO, Norway, April 3, 2019 /PRNewswire/ -- Nordic Nanovector ASA has today published its 2018 Annual Report, including the complete 2018 Annual Accounts with notes. This report is attached to this announcement and available on Nordic Nanovector ASA's website: Read more ››

MONTE-CARLO, Monaco, April 3, 2019 /PRNewswire/ -- Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announces the launch of its newest platform, the Legend Pro+™,... Read more ››

PARIS and NES ZIONA, Israel, April 3, 2019 /PRNewswire/ -- Laboratoires FILLMED (formerly Laboratoires Filorga Medical) and NanoPass have recently signed a private label agreement to co-brand NanoPass's microneedle-based device, NANOSOFT™, to be used with FILLMED's NCTF(®) 135 HA polyrevitalizing... Read more ››

LONDON, April 3, 2019 /PRNewswire/ -- We are delighted to announce Oviva, a digital health company transforming how we treat obesity and type 2 diabetes, in partnership with ICS Health & Wellbeing, has been successful in achieving a place on the new NHS England Diabetes Prevention Programme... Read more ››

HERTFORDSHIRE, England and PITTSBURGH, April 3, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ:MYL) is committed to doing... Read more ››

LONDON, April 1, 2019 /PRNewswire/ -- Lyophilized Injectable Drugs Market - Overview

This report analyzes the current and future scenario of the global lyophilized injectable drugs market.Lyophilization is a freeze drying process used for the removal of water from the final... Read more ››

TORONTO, April 1, 2019 /PRNewswire/ --

TORONTO, April 1, 2019 /PRNewswire/ - The University of Newcastle upon Tyne, UK ("Newcastle University") and Sagard Healthcare Royalty Partners ("SHRP") announced today that the University has sold to SHRP a portion of its royalty interest in a novel cancer drug, marketed as Rubraca, for a cash... Read more ››